THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point

Executive Summary

• Doseology Sciences Inc. acquired the Feed That Brain® brand for $400,000, to be paid via issuance of 175,000 common shares at $1.00 each and subsequent pre‑funded warrants ($75,000 every six months).
• The company appointed Joseph Mimran as a Strategic Advisor under a three‑year agreement valued at $400,000 in restricted share units, payable in equal installments.
• Both transactions are positioned to accelerate Doseology’s entry into the performance‑wellness market and expand its Canadian launch of next‑generation clean‑energy pouches.

Key Details

• Acquisition Price: $400,000 cash equivalent.
• Payment Structure: 175,000 common shares at $1.00 per share on closing; additional pre‑funded warrants worth $75,000 to be issued every six months thereafter.
• Target Brand: Feed That Brain® – a Toronto‑based cognitive health and beauty supplement line with distribution in >500 Canadian retail locations.
• Strategic Rationale: Leverage established brand equity to accelerate Doseology’s Canadian launch of clean‑energy pouches targeting the high‑growth energy‑drink and nicotine‑pouch markets (projected $125.1 B and >$25 B respectively by 2030).
• Advisor Appointment: Joseph Mimran, renowned retail strategist, engaged as Strategic Advisor for three years. Compensation: $400,000 in restricted share units, paid in equal quarterly installments.
• Leadership Team: CEO Chris Jackson; President & COO Tim Corkum; Go‑to‑Market Advisor Patrick Sills.
• Operational Footprint: National Canadian presence via functional mushroom tincture line; U.S. subsidiary (Doseology USA Inc.) developing caffeine/nootropic/adaptogen pouch products for professionals, students, and wellness consumers.

Notable Quotes

“Doseology is building something both innovative and timely,” said Joseph Mimran. “I’m excited to work alongside the team in shaping a brand that redefines how energy and performance can be delivered.”  — Joseph Mimran, Strategic Advisor

Materiality Assessment: Material – Positive (the acquisition and advisor appointment are expected to materially enhance Doseology’s market positioning and growth prospects).